Discussions with Pfizer and Moderna underway, trying to get solution on contractual issues: VK Paul

·1-min read
Dr V K Paul, Member (Health), NITI Aayog speaking to ANI in New Delhi on Friday.
Dr V K Paul, Member (Health), NITI Aayog speaking to ANI in New Delhi on Friday.

By Shalini Bhardwaj

New Delhi [India], July 9 (ANI): The Government of India is holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer over several issues including indemnity waiver, said Dr V K Paul, Member (Health), NITI Aayog on Friday.

"We are in touch with them (Moderna and Pfizer). We are holding discussions. It is a process of negotiation and dialogues. We are trying to get a solution on contractual and commitments issues. This process is ongoing," Dr Paul told ANI.

In June, US biotechnology company Moderna announced that India has granted permission for its COVID-19 vaccine to be imported into the country for restricted use in an emergency situation.

Pfizer has not even applied for an emergency use authorisation in the country.

Moderna and Pfizer had sought indemnity which would ensure that they can't be booked in case of any adverse effect of the vaccine. (ANI)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting